High‐frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats
暂无分享,去创建一个
Rudolf Morgenstern | Andreas Kupsch | Daniel Harnack | A. Kupsch | W. Meissner | C. Winter | R. Reese | M. Ansorge | D. Harnack | T. Reum | R. Morgenstern | G. Paul | René Reese | Christine Winter | Wassilios Meissner | Gesine Paul | Torsten Reum | Mark Ansorge | Heike Kusserow | H. Kusserow
[1] Y. Miyashita,et al. Quantification of neurotrophin-3 mRNA in the rat hippocampal subregions using the RT-PCR-based coamplification method. , 1999, Brain research. Brain research protocols.
[2] A Benazzouz,et al. Stimulation of subthalamic nucleus alleviates tremor in Parkinson's disease , 1997, The Lancet.
[3] R. Duvoisin,et al. Treatment of parkinsonism with levodopa. , 1969, Archives of neurology.
[4] U. Ungerstedt,et al. In Vivo Measurement of Dopamine and Its Metabolites by Intracerebral Dialysis: Changes After d‐Amphetamine , 1983, Journal of neurochemistry.
[5] R. Roth,et al. Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid. , 1976, European journal of pharmacology.
[6] J. Bowyer,et al. Long-term effects of amphetamine neurotoxicity on tyrosine hydroxylase mRNA and protein in aged rats. , 1998, The Journal of pharmacology and experimental therapeutics.
[7] P. Waldmeier,et al. Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism , 1976, Naunyn-Schmiedeberg's Archives of Pharmacology.
[8] D. Palm,et al. Rates of recovery of irreversibly inhibited monoamine oxidases: A measure of enzyme protein turnover , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[9] J. B. Justice,et al. Modeling the dopaminergic nerve terminal , 1988, Journal of Neuroscience Methods.
[10] R. Roth,et al. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo. , 1986, The Journal of pharmacology and experimental therapeutics.
[11] A. Kupsch,et al. High frequency stimulation of the subthalamic nucleus influences striatal dopaminergic metabolism in the naive rat , 2000 .
[12] K. Krnjević,et al. Intracellular actions of monoamine transmitters. , 1978, Canadian journal of physiology and pharmacology.
[13] Rudolf Morgenstern,et al. Deep brain stimulation of subthalamic neurons increases striatal dopamine metabolism and induces contralateral circling in freely moving 6-hydroxydopamine-lesioned rats , 2002, Neuroscience Letters.
[14] M. Matsunaga,et al. Reserpine Pretreatment Prevents Increases in Extracellular Striatal Dopamine Following L‐DOPA Administration in Rats with Nigrostriatal Denervation , 2000, Journal of neurochemistry.
[15] G. Gerhardt,et al. Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats , 1999, Brain Research.
[16] J. Richards,et al. In vivo dialysis measurements of dopamine and DOPAC in rats trained to turn on a circular treadmill , 1990, Pharmacology Biochemistry and Behavior.
[17] E. Krebs,et al. ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[18] F. Windels,et al. High Frequency Stimulation of the Subthalamic Nucleus Increases the Extracellular Contents of Striatal Dopamine in Normal and Partially Dopaminergic Denervated Rats , 2001, Journal of neuropathology and experimental neurology.
[19] A. Benabid,et al. Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease , 1997, The Lancet.
[20] D. Segal,et al. Tyrosine hydroxylase activity: Regional and subcellular distribution in brain , 1974 .
[21] M. Hallett,et al. Mechanism of action of deep brain stimulation. , 2000, Neurology.
[22] J. D. Parkes,et al. Fluctuations of disability in Parkinson's disease – clinical aspects , 1981 .
[23] K. Fuxe,et al. SITE OF ACTION OF RESERPINE. , 2009, Acta pharmacologica et toxicologica.
[24] N. Ozaki,et al. Differential effect of self-stimulation on dopamine release and metabolism in the rat medial frontal cortex, nucleus accumbens and striatum studied by in vivo microdialysis , 1992, Brain Research.
[25] G. Arbuthnott,et al. Brain microdialysis studies on the control of dopamine release and metabolism in vivo , 1990, Journal of Neuroscience Methods.
[26] D. Segal,et al. Reserpine enhances amphetamine stereotypies without increasing amphetamine-induced changes in striatal dialysate dopamine , 1989, Brain Research.
[27] A. Medvedev,et al. The stimulating effects of ethanol consumption on synthesis of rat brain monoamine oxidases and their sensitivity to the irreversible inhibitor, pargyline , 2000, Neuroscience Letters.
[28] G. Arbuthnott,et al. Dopamine release and metabolism in the rat striatum: an analysis by 'in vivo' brain microdialysis. , 1990, Pharmacology & therapeutics.
[29] K. Vrana,et al. Intricate Regulation of Tyrosine Hydroxylase Activity and Gene Expression , 1996, Journal of neurochemistry.
[30] R. Lindberg,et al. Metabolism of nomifensine after oral and intravenous administration , 1986, Clinical pharmacology and therapeutics.
[31] N. Wetzel. SURGICAL TREATMENT OF PARKINSON'S DISEASE. , 1963, Chicago medicine.
[32] O. J. Broch,et al. On the mode of action of reserpine on dopamine metabolism in the rat striatum. , 1971, European journal of pharmacology.
[33] A. Benabid,et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 1998, The New England journal of medicine.
[34] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[35] L. Swanson. The Rat Brain in Stereotaxic Coordinates, George Paxinos, Charles Watson (Eds.). Academic Press, San Diego, CA (1982), vii + 153, $35.00, ISBN: 0 125 47620 5 , 1984 .
[36] G. Arbuthnott,et al. Amphetamine‐Induced Dopamine Release in the Rat Striatum: An In Vivo Microdialysis Study , 1988, Journal of neurochemistry.
[37] A. Kupsch,et al. Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats , 2001, Neuroscience Letters.
[38] T. Hökfelt,et al. Dopamine D2 receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum , 2001, The European journal of neuroscience.
[39] A. Benabid,et al. Long‐Term Electrical Inhibition of Deep Brain Targets in Movement Disorders , 2008, Movement disorders : official journal of the Movement Disorder Society.
[40] O. Hornykiewicz,et al. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. , 1960, Parkinsonism & related disorders.
[41] T. Lee,et al. A microdialysis study on striatal dopamine, 5‐HT and metabolites in conscious rats after various treatments: evidence for extravesicular release of dopamine , 1993, Neuroreport.
[42] R. Roth,et al. Dopamine Synthesis, Uptake, Metabolism, and Receptors: Relevance to Gene Therapy of Parkinson's Disease , 1997, Experimental Neurology.
[43] Anders Björklund,et al. Regional differences in the regulation of dopamine and noradrenaline release in medial frontal cortex, nucleus accumbens and caudate-putamen: a microdialysis study in the rat , 1992, Brain Research.
[44] T. Kato,et al. Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography. , 1979, Journal of chromatography.
[45] G. Arbuthnott,et al. Effects of Selective Monoamine Oxidase Inhibitors on the In Vivo Release and Metabolism of Dopamine in the Rat Striatum , 1990, Journal of neurochemistry.
[46] G. Chiara,et al. Stimulation of dopamine transmission in the dorsal caudate nucleus by pargyline as demonstrated by dopamine and acetylcholine microdialysis and Fos immunohistochemistry , 1993, Neuroscience.
[47] G. Di Chiara,et al. Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[48] H. Ehringer,et al. Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen Systems , 2005, Klinische Wochenschrift.
[49] M. Naoi,et al. Simple assay procedure for tyrosine hydroxylase activity by high-performance liquid chromatography employing coulometric detection with minimal sample preparation. , 1988, Journal of chromatography.
[50] M. Garcia-Munoz,et al. Electrophysiological analysis of dopamine cells from the substantia nigra pars compacta of circling rats , 2004, Experimental Brain Research.
[51] U. Ungerstedt,et al. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. , 1988, European journal of pharmacology.
[52] F. Bergquist,et al. 3‐Methoxytyramine Formation Following Monoamine Oxidase Inhibition Is a Poor Index of Dendritic Dopamine Release in the Substantia Nigra , 1997, Journal of neurochemistry.